Yilong Wang
Capital Medical University
626 Papers
1.2K Citations
Yilong Wang is an academic researcher from Capital Medical University. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 42, co-authored 429 publications.
Chat about Author
Papers
Risk Assessment of Deep-Vein Thrombosis After Acute Stroke: a Prospective Study Using Clinical Factors
Liping Liu,Huaguang Zheng,David Z. Wang,Yilong Wang,Mohammed Hussain,Haixin Sun,Anxin Wang,Xingquan Zhao,Kehui Dong,Chunxue Wang,Wen He,Bin Ning,Yongjun Wang +12 more
TL;DR: To assess the risk of deep venous thrombosis in acute stroke patients, a clinical score was developed and validated in a cohort study and may help with formulating a proper prevention strategy.
Clinical Characteristics, Management, and Functional Outcomes in Chinese Patients Within the First Year After Intracerebral Hemorrhage: Analysis from China National Stroke Registry
Wenjuan Wang,Jingjing Lu,Yongjun Wang,Chunxue Wang,Yilong Wang,Kolin Hoff,Zhonghua Yang,Liping Liu,Anxin Wang,Xingquan Zhao +9 more
TL;DR: The aim of this study was to understand the association between clinical characteristics, medical management, and functional outcomes in Chinese patients with nontraumatic intracerebral hemorrhage.
Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China
Xiaomeng Yang,Zixiao Li,Xingquan Zhao,Chunjuan Wang,Liping Liu,Chunxue Wang,Yuesong Pan,Hao Li,David Wang,Robert G. Hart,Yilong Wang,Yongjun Wang +11 more
TL;DR: The rate of warfarin use remains low among patients with ischemic stroke and known nonvalvular atrial fibrillation in China, and hospital size and academic status together with patient age, heart failure, heavy alcohol drinking, international normalized ratio in hospital, and stroke severity on admission were each independently associated with the use of warFarin at discharge.
59
Implementation and outcome of thrombolysis with alteplase 3 to 4.5 h after acute stroke in Chinese patients.
Xiaoling Liao,Chunxue Wang,Yilong Wang,Chunjuan Wang,Xingquan Zhao,Liqun Zhang,Liping Liu,Yuesong Pan,Yongjun Wang +8 more
TL;DR: The European Cooperative Acute Stroke Study (ECASS) III showed that intravenous recombinant tissue plasminogen activator administered in the 3 to 4.5 h after symptom onset significantly improved clinical outcomes in patients with acute ischemic stroke.
Acute Effects of Particulate Air Pollution on Ischemic Stroke and Hemorrhagic Stroke Mortality.
Runhua Zhang,Gaifen Liu,Yong Jiang,Gang Li,Yuesong Pan,Yilong Wang,Zaihua Wei,Jing Wang,Yongjun Wang +8 more
TL;DR: Short-term exposure to ambient PM was associated with the risk of stroke mortality and the associations between PM10 and mortality were also detected for cerebrovascular diseases and ischemic stroke, but not in hemorrhagic stroke.